PlainRecalls
FDA Drug Low Class III Terminated

Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709

Reported: September 19, 2018 Initiated: August 14, 2018 #D-1188-2018

Product Description

Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709

Reason for Recall

Defective Delivery System: Water ingress through the lower water cup sensor of the device.

Details

Recalling Firm
United Therapeutics Corp.
Units Affected
2801 devices
Distribution
IL, PA
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709. Recalled by United Therapeutics Corp.. Units affected: 2801 devices.
Why was this product recalled?
Defective Delivery System: Water ingress through the lower water cup sensor of the device.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 19, 2018. Severity: Low. Recall number: D-1188-2018.